MIIP is a newly identified tumor suppressor in many different types of cancer, including glioma, lung cancer, colon cancer, endometrial carcinoma, pancreatic cancer and others [18–20, 22, 24, 25], yet its role in prostate cancer has not been reported and its biological function and the relevant mechanism is far from clarified. Here, MIIP is linked to central nervous system cancer.